| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |